Clinical efficacy of laparoscopic surgery combined with drug therapy for endometriosis: A meta-analysis
Systematic review / meta-analysis
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
Laparoscopic surgery combined with drug therapy for endometriosis showed higher efficacy, pregnancy rates, and lower recurrence and adverse reaction rates compared to surgery alone.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To systematically investigate the clinical efficacy and prognosis of laparoscopic surgery combined with drug therapy for endometriosis.
METHODS: Clinical randomized controlled trials regarding laparoscopic surgery combined with drug therapy for endometriosis and published between 2010 and 2022 were retrieved from PubMed, Web of Science and Embase, China National Knowledge Infrastructure, and Wanfang databases. Meta-analysis and sensitivity tests were performed using the Stata16.0 software.
RESULTS: A total of 1332 articles were retrieved. Of them, 11 studies were included for final analysis, comprising of 521 cases in the treatment group (laparoscopic surgery combined with drug therapy) and 530 cases in the control group (laparoscopic surgery alone). Meta-analysis results showed that compared with the control group, the combined treatment had higher treatment effective rate [OR = 4.542, 95% CI (3.062, 6.736), P < 0.001], pregnancy rate [OR = 3.341, 95% CI (2.336, 4.780), P < 0.001], and lower incidence of adverse reactions [OR = 0.348, 95% CI (0.208, 0.583), P < 0.001] and recurrence rate [OR = 0.187, 95% CI (0.106, 0.328), P < 0.001]. In addition, after treatment, estradiol [SMD = -3.417, 95% CI (-4.631, -2.203), P < 0.001] and follicle-stimulating hormone [SMD = -1.976, 95% CI (-3.202, -0.751), P = 0.002] in the treatment group were significantly lower than the control group.
CONCLUSION: Compared with laparoscopic surgery alone, laparoscopic surgery combined with drug therapy demonstrated better clinical efficacy and improved postoperative infertility and recurrence rate for treating endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (14)
- Consensus on current management of endometriosis via openalex
- Endometriosis-related infertility: ovarian endometrioma per se is not associated with presentation for infertility via openalex
- Estradiol promotes EMT in endometriosis via MALAT1/miR200s sponge function via openalex
- Excisional surgery versus ablative surgery for ovarian endometriomata: a Cochrane Review via openalex
- Post-surgical ovarian failure after laparoscopic excision of bilateral endometriomas: is this rare problem preventable? via openalex
- Relationship between stage, site and morphological characteristics of pelvic endometriosis and pain via openalex
- Repetitive surgery for recurrent symptomatic endometriosis: what to do? via openalex
- Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions via openalex
- The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis via openalex
- The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval via openalex
- W2343074999 via openalex
- W2810127666 via openalex
- W2037054089 via openalex
- W4234160457 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-10-16T06:09:50.462052+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:36:33.795939+00:00
- unpaywall
- last seen: 2026-10-16T06:24:35.758740+00:00
License: CC0
· commercial use OK